CEBPA and acute myeloid leukemia: In this study, we demonstrated that 2-HG mediates the activation of VDR pathway through CEBPα in IDHMUT AML, sensitizing IDHMUT AML cells to the differentiation-based ATRA/VD doublet therapy.